Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

New treatments for Alopecia Areata show promise but need to be more effective and affordable.

Lupus can look like hair loss from alopecia areata but needs different treatment.

Regenerative therapies show promise for treating vitiligo and alopecia areata.

Current treatments for alopecia show no significant long-term benefits.

Sex hormones may affect COVID-19 severity, with men often faring worse, and targeting related pathways could offer treatment options.

Mice genetically modified to produce more CD109 in their skin had less inflammation and better healing with less scarring.

Low vitamin D levels are common in people with Alopecia Areata.

Different types of Armillaria fungus have a high genetic variety when partnering with Polyporus umbellatus mushrooms in China.

Understanding the immune-related causes of Alopecia Areata has led to potential treatments like JAK inhibitors.

People with alopecia areata often have lower levels of vitamin D, zinc, and folate, but more research is needed to understand if supplements can help treat it.

People with late-stage HIV-1 often experience a specific type of hair loss linked to multiple factors, including nutritional issues and immune responses.

Plasmacytoid dendritic cells are a key factor in causing hair loss in alopecia areata and could help differentiate it from other hair loss conditions.

No treatments fully cure or prevent alopecia areata; some help but have side effects or need more research.

Patients with Alopecia areata have fewer specific immune cells that normally regulate the immune system, which may contribute to the condition.

The PRP-like cosmetic product with postbiotics effectively treats hair loss in Alopecia areata.

Using tiny fat particles to deliver arginine to hair follicles could be a new way to treat hair loss.

People with alopecia areata have higher rates of mental health issues, autoimmune diseases, and infections.

Both topical calcipotriol and narrowband UVB improved alopecia, but combining them didn't enhance the effect on hair loss severity, despite higher vitamin D3 levels.

Alopecia areata causes unpredictable hair loss and emotional distress, with no cure and limited treatment options.

A new gene mutation causes insulin resistance in a girl and her mother.

PRP may help hair growth in alopecia areata without major side effects, but more research is needed.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

Certain genetic markers linked to reproductive potential were identified by their impact on a protein's ability to bind to genes.

Japanese patients and physicians often disagree on the severity of Alopecia Areata and treatment satisfaction, needing better communication and treatments.

No effective treatment for frontal fibrosing alopecia was found, but oral 5-alpha-reductase inhibitors had the best response; for lichen planopilaris, topical corticosteroids were commonly used but had a high relapse rate.

Some drugs may reduce prostatitis symptoms short-term with few side effects.

Hair growth is influenced by hormones and goes through different phases; androgens can both promote and inhibit hair growth depending on the body area.

Finasteride cream reduces hair growth in women with hirsutism, but more research needed.

Modern wound dressings like hydrocolloids, alginates, and hydrogels improve healing and are cost-effective.